Open Access Green as soon as Postprint is submitted to ZB.
Burkitt lymphoma: The role of Epstein-Barr virus revisited.
Br. J. Haematol. 156, 719-729 (2012)
The particular epidemiological features of Burkitt lymphoma (BL) in Tropical Africa, first described by Denis Burkitt in 1958, initiated the search for a virus that induces malignant B cell lymphomas in humans and is transmitted by arthropods. The herpes virus (Epstein-Barr virus, EBV) discovered by Epstein and collaborators in cell lines established from BL biopsies fulfilled some of these predictions. It drives primary B cells into unlimited proliferation, induces malignant B cell lymphomas in immunocompromised individuals (post-transplant lymphoproliferative disease, PTLD) in vivo, and footprints of the virus are generally detected in African BL biopsies supporting a causative role of the virus in the pathogenesis of BL. The virus is, however, not transmitted by arthropods and is spread ubiquitously amongst the human population through saliva. Furthermore, BL and EBV-induced PTLD are now recognized as pathogenetically distinct entities: BL involves MYC-immunoglobulin translocations in contrast to PTLD, and different patterns of viral genes are expressed in both diseases. Viral gene products expressed in BL are assumed to contribute to inhibition of apoptosis, although their precise mechanism of action is not fully understood. In the future, next generation sequencing is expected to shed more light on the contribution of EBV to the pathogenesis of BL.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
4.941
1.563
18
20
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Burkitt lymphoma; Epstein-Barr virus; infectious disease
Language
Publication Year
2012
HGF-reported in Year
2012
ISSN (print) / ISBN
0007-1048
e-ISSN
1365-2141
Journal
British Journal of Haematology
Quellenangaben
Volume: 156,
Issue: 6,
Pages: 719-729
Publisher
Wiley
Reviewing status
Peer reviewed
Institute(s)
Institute of Clinical Molecular Biology and Tumor Genetics (K.MOLBI)
CCG Pediatric Tumor Immunology (AGV-KPT)
CCG Pediatric Tumor Immunology (AGV-KPT)
POF-Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501400-001
G-520900-001
G-520900-001
PubMed ID
22482131
WOS ID
WOS:000300972200005
Scopus ID
84857788752
Erfassungsdatum
2012-04-23